ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of ALKS33 (RDC-0313) compared with placebo
in adults with alcohol dependence. There will be 11 study visits conducted over a period of
about 4 months. The study period includes a screening visit, a 12-week treatment period, and
a follow-up visit.